D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBI
3201
PUT
DELISTED
Hanesbrands
HBI
| $427K | ﹤0.01% |
+54,300
| New | +$688K |
|
|
CCRN
3202
DELISTED
Cross Country Healthcare
CCRN
| $426K | ﹤0.01% |
63,175
+45,675
| +261% | +$433K |
|
3203
CALL
CRISPR Therapeutics
CRSP
$4.58B
| $424K | ﹤0.01% |
10,000
| – | – |
|
3204
Hasbro
HAS
$12.6B
| $424K | ﹤0.01% |
+5,920
| New | +$512K |
|
|
TWOU
3205
CALL
DELISTED
2U Inc
TWOU
| $424K | ﹤0.01% |
+667
| New | +$451K |
|
|
HHR
3206
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $423K | ﹤0.01% |
26,506
+3,593
| +16% | +$75.2K |
|
3207
PUT
Macerich
MAC
$7.32B
| $420K | ﹤0.01% |
74,600
-58,500
| -44% | -$1.16M |
|
3208
NexGen Energy
NXE
$6.05B
| $419K | ﹤0.01% |
545,700
+375,600
| +221% | +$374K |
|
3209
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $418K | ﹤0.01% |
+47,500
| New | +$497K |
|
3210
PUT
Cencora
COR
$60.3B
| $416K | ﹤0.01% |
+4,700
| New | +$414K |
|
3211
National Bank Holdings
NBHC
$1.93B
| $414K | ﹤0.01% |
17,309
-11,245
| -39% | -$351K |
|
3212
Kelly Services Class A
KELYA
$526M
| $412K | ﹤0.01% |
32,470
+14,928
| +85% | +$260K |
|
|
DCPH
3213
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $412K | ﹤0.01% |
10,000
| – | – |
|
3214
Horace Mann Educators
HMN
$2.1B
| $411K | ﹤0.01% |
11,230
-7,735
| -41% | -$319K |
|
3215
Westamerica Bancorp
WABC
$1.39B
| $410K | ﹤0.01% |
6,973
-14,807
| -68% | -$920K |
|
3216
Chunghwa Telecom
CHT
$33.2B
| $409K | ﹤0.01% |
+11,493
| New | +$414K |
|
|
SIEN
3217
DELISTED
Sientra, Inc.
SIEN
| $409K | ﹤0.01% |
20,553
-39,951
| -66% | -$2.09M |
|
|
MOBL
3218
DELISTED
MobileIron, Inc.
MOBL
| $409K | ﹤0.01% |
107,737
-291,044
| -73% | -$1.25M |
|
3219
Malibu Boats
MBUU
$544M
| $408K | ﹤0.01% |
14,180
-29,685
| -68% | -$1.18M |
|
|
MSGN
3220
PUT
DELISTED
MSG Networks Inc.
MSGN
| $408K | ﹤0.01% |
+40,000
| New | +$571K |
|
|
STFC
3221
DELISTED
State Auto Financial Corp
STFC
| $405K | ﹤0.01% |
14,558
+1,400
| +11% | +$40K |
|
|
MIXT
3222
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $403K | ﹤0.01% |
46,577
-28,673
| -38% | -$353K |
|
3223
CALL
TechnipFMC
FTI
$30.6B
| $402K | ﹤0.01% |
+80,102
| New | +$879K |
|
3224
PUT
Criteo
CRTO
$1.03B
| $401K | ﹤0.01% |
50,500
+10,500
| +26% | +$134K |
|
3225
Lands' End
LE
$361M
| $401K | ﹤0.01% |
75,151
-174,563
| -70% | -$1.87M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.